These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 28624183)
1. The neuroprotective effect of perampanel in lithium-pilocarpine rat seizure model. Wu T; Ido K; Osada Y; Kotani S; Tamaoka A; Hanada T Epilepsy Res; 2017 Nov; 137():152-158. PubMed ID: 28624183 [TBL] [Abstract][Full Text] [Related]
2. Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus. Trandafir CC; Pouliot WA; Dudek FE; Ekstrand JJ Neuroscience; 2015 Jan; 284():601-610. PubMed ID: 25453777 [TBL] [Abstract][Full Text] [Related]
3. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. André V; Rigoulot MA; Koning E; Ferrandon A; Nehlig A Epilepsia; 2003 Jul; 44(7):893-903. PubMed ID: 12823571 [TBL] [Abstract][Full Text] [Related]
4. Effect of perampanel, a novel AMPA antagonist, on benzodiazepine-resistant status epilepticus in a lithium-pilocarpine rat model. Hanada T; Ido K; Kosasa T Pharmacol Res Perspect; 2014 Oct; 2(5):e00063. PubMed ID: 25505607 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy. Rigoulot MA; Koning E; Ferrandon A; Nehlig A J Pharmacol Exp Ther; 2004 Feb; 308(2):787-95. PubMed ID: 14593082 [TBL] [Abstract][Full Text] [Related]
6. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. François J; Koning E; Ferrandon A; Nehlig A Epilepsy Res; 2006 Dec; 72(2-3):147-63. PubMed ID: 16945504 [TBL] [Abstract][Full Text] [Related]
7. Perampanel but Not Amantadine Prevents Behavioral Alterations and Epileptogenesis in Pilocarpine Rat Model of Status Epilepticus. Mohammad H; Sekar S; Wei Z; Moien-Afshari F; Taghibiglou C Mol Neurobiol; 2019 Apr; 56(4):2508-2523. PubMed ID: 30039334 [TBL] [Abstract][Full Text] [Related]
8. Metyrapone prevents brain damage induced by status epilepticus in the rat lithium-pilocarpine model. García-García L; Shiha AA; Fernández de la Rosa R; Delgado M; Silván Á; Bascuñana P; Bankstahl JP; Gomez F; Pozo MA Neuropharmacology; 2017 Sep; 123():261-273. PubMed ID: 28495374 [TBL] [Abstract][Full Text] [Related]
9. Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers. Brandt C; Töllner K; Klee R; Bröer S; Löscher W Neurobiol Dis; 2015 Mar; 75():78-90. PubMed ID: 25549873 [TBL] [Abstract][Full Text] [Related]
10. Prolonged low-dose caffeine exposure protects against hippocampal damage but not against the occurrence of epilepsy in the lithium-pilocarpine model in the rat. Rigoulot MA; Leroy C; Koning E; Ferrandon A; Nehlig A Epilepsia; 2003 Apr; 44(4):529-35. PubMed ID: 12681001 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats. Langer M; Brandt C; Zellinger C; Löscher W Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883 [TBL] [Abstract][Full Text] [Related]
12. Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure. Tetz LM; Rezk PE; Ratcliffe RH; Gordon RK; Steele KE; Nambiar MP Toxicol Ind Health; 2006 Jul; 22(6):255-66. PubMed ID: 16924957 [TBL] [Abstract][Full Text] [Related]
13. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444 [TBL] [Abstract][Full Text] [Related]
14. Comparison of neuroprotective effects induced by alpha-phenyl-N-tert-butyl nitrone (PBN) and N-tert-butyl-alpha-(2 sulfophenyl) nitrone (S-PBN) in lithium-pilocarpine status epilepticus. Peterson SL; Purvis RS; Griffith JW Neurotoxicology; 2005 Dec; 26(6):969-79. PubMed ID: 15890407 [TBL] [Abstract][Full Text] [Related]
15. Electroshocks delay seizures and subsequent epileptogenesis but do not prevent neuronal damage in the lithium-pilocarpine model of epilepsy. André V; Ferrandon A; Marescaux C; Nehlig A Epilepsy Res; 2000 Nov; 42(1):7-22. PubMed ID: 10996502 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of ketamine administered after status epilepticus onset. Fujikawa DG Epilepsia; 1995 Feb; 36(2):186-95. PubMed ID: 7821277 [TBL] [Abstract][Full Text] [Related]
17. Gastrodin alleviates seizure severity and neuronal excitotoxicities in the rat lithium-pilocarpine model of temporal lobe epilepsy via enhancing GABAergic transmission. Yang CS; Chiu SC; Liu PY; Wu SN; Lai MC; Huang CW J Ethnopharmacol; 2021 Apr; 269():113751. PubMed ID: 33359863 [TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus. Li YJ; Wang L; Zhang B; Gao F; Yang CM J Pharm Pharmacol; 2019 Mar; 71(3):390-399. PubMed ID: 30417405 [TBL] [Abstract][Full Text] [Related]
19. Lovastatin reduces neuronal cell death in hippocampal CA1 subfield after pilocarpine-induced status epilepticus: preliminary results. Rangel P; Cysneiros RM; Arida RM; de Albuquerque M; Colugnati DB; Scorza CA; Cavalheiro EA; Scorza FA Arq Neuropsiquiatr; 2005 Dec; 63(4):972-6. PubMed ID: 16400415 [TBL] [Abstract][Full Text] [Related]
20. Combined diazepam and HDAC inhibitor treatment protects against seizures and neuronal damage caused by soman exposure. Rossetti F; de Araujo Furtado M; Pak T; Bailey K; Shields M; Chanda S; Addis M; Robertson BD; Moffett M; Lumley LA; Yourick DL Neurotoxicology; 2012 Jun; 33(3):500-11. PubMed ID: 22387230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]